Inventor · disambiguated record
Marianne Dorothy Sadar
Also filed as: SADAR MARIANNE D · SADAR MARIANNE DOROTHY
18 granted patents·17 pending applications·151 citations·filing 2009–2024
94Inventor score
Files withUNIV BRITISH COLUMBIA16BRITISH COLUMBIA CANCER AGENCY BRANCH5ESSA PHARMA INC4SADAR MARIANNE D4BRITISH COLUMBIA CANCER AGENCY3
Top patents by PatentIndex Score
35 records- 0197US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0295US11345670B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2020·Granted May 31, 2022·5 cites·31 claims
- 0394US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 0494US11142508B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 12, 2021·4 cites·24 claims
- 0594US10654811B2Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2016·Granted May 19, 2020·11 cites·37 claims
- 0694US9365510B2Aziridine bisphenol ethers and related compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Jun 14, 2016·16 cites·46 claims
- 0793US8686050B2Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2013·Granted Apr 1, 2014·19 cites·14 claims
- 0892US9173939B2Ester derivatives of androgen receptor modulators and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Nov 3, 2015·20 cites·29 claims
- 0989US9862667B2Diglycidic ether derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2009·Granted Jan 9, 2018·14 cites·45 claims
- 1087US9388112B2Bisphenol derivatives and their use as androgen receptor activity modulatorsSADAR MARIANNE D·Filed 2011·Granted Jul 12, 2016·15 cites·34 claims
- 1187US9375496B2Halogenated compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2014·Granted Jun 28, 2016·16 cites·23 claims
- 1286US10471023B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2016·Granted Nov 12, 2019·5 cites·28 claims
- 1385US2025100986A1Bisphenol derivatives and their use as androgen receptor activity modulatorsPROVINCIAL HEALTH SERVICES AUTHORITY·Filed 2024·Application pending·0 cites
- 1484US2024391883A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 1575US11919874B2Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 1675US9682933B2Androgen receptor modulators and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2015·Granted Jun 20, 2017·2 cites·30 claims
- 1775US9487479B2Small molecule inhibitors of N-terminus activation of the androgen receptorSADAR MARIANNE D·Filed 2009·Granted Nov 8, 2016·2 cites·54 claims
- 1875US2022267283A1Heterocyclic compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 1969US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 2067US11779550B2Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2020·Granted Oct 10, 2023·0 cites·10 claims
- 2159US2020206155A1Bisphenol ether derivatives and methods for using the sameUNIV BRITISH COLUMBIA·Filed 2019·Application pending·0 cites
- 2258US12109179B2Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2020·Granted Oct 8, 2024·0 cites·23 claims
- 2357US2018235925A1Bisphenol compounds and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Application pending·0 cites
- 2456US2017298033A1Bisphenol derivatives and their use as androgen receptor activity modulatorsUNIV BRITISH COLUMBIA·Filed 2017·Application pending·0 cites
- 2554US2025009685A1Hydroxyphenyl-ethynyl-phenol derivatives as ar (androgen receptor) transcriptional activity modulators for use in the treatment of i.a. prostate cancerFUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA·Filed 2022·Application pending·0 cites
- 2653US2014248263A1Bisphenol compounds and methods for their useANDERSEN RAYMOND JOHN·Filed 2012·Application pending·0 cites
- 2752US2015010469A1Bisphenol ether compounds with novel bridging groups and methods for their useBRITISH COLUMBIA CANCER AGENCY·Filed 2014·Application pending·0 cites
- 2851US2017121261A1Diglycidic ether derivative therapeutics and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2016·Application pending·0 cites
- 2947US10071962B2Androgen receptor modulators and methods for their useBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2017·Granted Sep 11, 2018·0 cites·23 claims
- 3045US2017239216A1Small molecule inhibitors of n-terminus activation of the androgen receptorUNIV BRITISH COLUMBIA·Filed 2016·Application pending·0 cites
- 3143US2017056336A1Co-targeting androgen receptor splice variants and mtor signaling pathway for the treatment of castration-resistant prostate cancerBRITISH COLUMBIA CANCER AGENCY BRANCH·Filed 2016·Application pending·0 cites
- 3242US2016068466A1Ester derivatives of androgen receptor modulators and methods for their useUNIV BRITISH COLUMBIA·Filed 2015·Application pending·0 cites
- 3341US2013045204A1Fluorinated bisphenol ether compounds and methods for their useUNIV BRITISH COLUMBIA·Filed 2012·Application pending·0 cites
- 3441US2016367707A1Halogenated compounds for cancer imaging and treatment and methods for their useUNIV BRITISH COLUMBIA·Filed 2016·Application pending·0 cites
- 3535US2013109758A1Bisphenol derivative therapeutics and methods for their useSADAR MARIANNE D·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marianne Dorothy Sadar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →